Clinical Trial Update: Postoperative Adjuvant TACE Treatment in CK18 Positive Patients

View source ↗

Summary

A completed trial evaluating postoperative adjuvant transarterial chemoembolization in CK18-positive hepatocellular carcinoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Postoperative Adjuvant TACE, Hepatocellular Carcinoma. | Status: COMPLETED